In This Section:

◄
►

Amyloidosis

See more ▼
Close X
Other videos you might like

Recent Videos

AHA 24: Nexiguran Ziclumeran for ATTR-CM

Video

AHA 24: Nexiguran Ziclumeran for ATTR-CM

Marianna Fontana,

Watch time: 5m 6s
ESC 24: 3 Trials That Will Change My Practice

Video

ESC 24: 3 Trials That Will Change My Practice

Michelle Kittleson,

Watch time: 13m 47s
ESC 24: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Video

ESC 24: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi,

Watch time: 17m 25s
HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie

Video

HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie

Harriette Van Spall, Mark Petrie,

Watch time: 15m 26s
ESC 23: ATTRibute-CM Trial

Video

ESC 23: ATTRibute-CM Trial

Julian Gillmore,

Watch time: 4m 39s
Potential Reversibility of ATTR-CM through Anti-ATTR Amyloid Antibodies

Video

Potential Reversibility of ATTR-CM through Anti-ATTR Amyloid Antibodies

Marianna Fontana,

Watch time: 8m 1s

Radcliffe Content

Amyloid Heart Disease

US Cardiology Review 2018;12(2):113–8.